GlaxoSmithKline lung drug Anoro approved in Europe

[Reuters – UK Focus] – GlaxoSmithKline said on Thursday its new inhaled lung drug, Anoro, had been approved in Europe as a treatment for chronic lung disease, boosting its respiratory franchise. A final green light had been … more

View todays social media effects on THRX

View the latest stocks trending across Twitter. Click to view dashboard

See who Theravance is hiring next, click here to view